Table 6.
Outcome comparisons in effect sizes, stratified by diagnosis. Each comparison refers to one SF-36 scale at the last evaluable follow-up of the corresponding cohort: Mean difference from baseline in AMOS cohort minus mean difference from baseline in corresponding cohort, divided by standard deviation of baseline score of AMOS cohort. A positive difference indicates that AMOS cohorts show larger improvements than corresponding cohorts.
| Diagnosis | Median | Interquartile range | Ranges: Number (percentage) of comparisons | N (total) | ||||||
| ≤ -0.8 | -0.79 to -0.5 | -0.49 to -0.2 | -0.19 to 0.19 | 0.2 to 0.49 | 0.5 to 0.79 | ≥ 0.8 | ||||
| Asthma | 0.05 | -0.18 to 0.30 | 1 (1) | 4 (5) | 13 (17) | 33 (43) | 18 (23) | 6 (8) | 2 (3) | 77 (100) |
| Depression | 0.17 | -0.09 to 0.37 | 3 (4) | 4 (5) | 6 (8) | 26 (33) | 28 (36) | 9 (12) | 2 (3) | 78 (100) |
| Low back pain | 0.12 | -0.12 to 0.33 | 9 (4) | 10 (5) | 22 (11) | 77 (38) | 57 (28) | 21 (10) | 6 (3) | 202 (100) |
| Migraine | 0.10 | -0.08 to 0.35 | 0 (0) | 2 (1) | 16 (11) | 77 (51) | 34 (23) | 14 (9) | 7 (5) | 150 (100) |
| Neck pain | 0.44 | 0.23 to 0.54 | 0 (0) | 0 (0) | 1 (10) | 1 (10) | 5 (50) | 3 (30) | 0 (0) | 10 (100) |
| Total | 0.11 | -0.11 to 0.35 | 13 (3) | 20 (4) | 58 (11) | 214 (41) | 142 (27) | 53 (10) | 17 (3) | 517 (100) |